|
1
|
He W, Qi B, Zhou Q, Lu C, Huang Q, Xian L
and Chen M: Key genes and pathways in thyroid cancer based on gene
set enrichment analysis. Oncol Rep. 30:1391–1397. 2013.
|
|
2
|
Geraldo MV and Kimura ET: Integrated
analysis of thyroid cancer public datasets reveals role of
post-transcriptional regulation on tumor progression by targeting
of immune system mediators. PLoS One. 10:e01417262015. View Article : Google Scholar :
|
|
3
|
Hu MI, Vassilopoulou-Sellin R, Lustig R
and Lamont JP: Thyroid and parathyroid cancers. Cancer Management:
A Multidisciplinary Approach. 11:2008.
|
|
4
|
Lodish MB and Stratakis CA: RET oncogene
in MEN2, MEN2B, MTC and other forms of thyroid cancer. Expert Rev
Anticancer Ther. 8:625–632. 2008. View Article : Google Scholar :
|
|
5
|
Santarpia L, Calin GA, Adam L, Ye L, Fusco
A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, et al: A
miRNA signature associated with human metastatic medullary thyroid
carcinoma. Endocr Relat Cancer. 20:809–823. 2013. View Article : Google Scholar
|
|
6
|
Hofstra R, Stelwagen T, Stulp RP, de Jong
D, Hulsbeek M, Kamsteeg EJ, van den Berg A, Landsvater RM, Vermey
A, Molenaar WM, et al: Extensive mutation scanning of RET in
sporadic medullary thyroid carcinoma and of RET and VHL in sporadic
pheochromocytoma reveals involvement of these genes in only a
minority of cases. J Clin Endocrinol Metab. 81:2881–2884. 1996.
View Article : Google Scholar
|
|
7
|
Soh EY, Duh QY, Sobhi SA, Young DM,
Epstein HD, Wong MG, Garcia YK, Min YD, Grossman RF, Siperstein AE
and Clark OH: Vascular endothelial growth factor expression is
higher in differentiated thyroid cancer than in normal or benign
thyroid. J Clin Endocrinol Metab. 82:3741–3747. 1997. View Article : Google Scholar
|
|
8
|
Maliszewska A, Leandro-Garcia LJ,
Castelblanco E, Macià A, de Cubas A, Goméz-López G, Inglada-Pérez
L, Álvarez-Escolá C, De la Vega L, Letón R, et al: Differential
gene expression of medullary thyroid carcinoma reveals specific
markers associated with genetic conditions. Am J Pathol.
182:350–362. 2013. View Article : Google Scholar
|
|
9
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar :
|
|
10
|
Pallante P, Visone R, Croce CM and Fusco
A: Deregulation of microRNA expression in follicular cell-derived
human thyroid carcinomas. Endocr Relat Cancer. 17:F91–F104. 2010.
View Article : Google Scholar
|
|
11
|
Visone R, Pallante P, Vecchione A,
Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V,
Borbone E, et al: Specific microRNAs are downregulated in human
thyroid anaplastic carcinomas. Oncogene. 26:7590–7595. 2007.
View Article : Google Scholar
|
|
12
|
He H, Jazdzewski KW, Li W, Liyanarachchi
S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et
al: The role of microRNA genes in papillary thyroid carcinoma. Proc
Natl Acad Sci USA. 102:pp. 19075–19080. 2005; View Article : Google Scholar :
|
|
13
|
Weber F, Teresi RE, Broelsch CE, Frilling
A and Eng C: A limited set of human microRNA is deregulated in
follicular thyroid carcinoma. J Clin Endocrinol Metab.
91:3584–3591. 2006. View Article : Google Scholar
|
|
14
|
Lassalle S, Zangari J, Popa A, Ilie M,
Hofman V, Long E, Patey M, Tissier F, Belléannée G, Trouette H, et
al: MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of
vandetanib. Oncotarget. 7:30461–30478. 2016.
|
|
15
|
Smyth GK: Limma: linear models for
microarray dataBioinformatics and computational biology solutions
using R and Bioconductor. Springer; New York, ΝΥ: pp. 397–420.
2005, View Article : Google Scholar
|
|
16
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar
|
|
17
|
Wang J, Lu M, Qiu C and Cui Q: TransmiR: A
transcription factor-microRNA regulation database. Nucleic Acids
Res. 38(Database issue): D119–D122. 2010. View Article : Google Scholar
|
|
18
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2. 0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42(Database issue): D92–D97. 2014. View Article : Google Scholar
|
|
19
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar
|
|
20
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human microRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar :
|
|
21
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar
|
|
22
|
Kertesz M, Iovino N, Unnerstall U, Gaul U
and Segal E: The role of site accessibility in microRNA target
recognition. Nat Genet. 39:1278–1284. 2007. View Article : Google Scholar
|
|
23
|
Ritchie W, Flamant S and Rasko JE:
Predicting microRNA targets and functions: Traps for the unwary.
Nat Methods. 6:397–398. 2009. View Article : Google Scholar
|
|
24
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar :
|
|
25
|
He X and Zhang J: Why do hubs tend to be
essential in protein networks? PLoS Genet. 2:e882006. View Article : Google Scholar :
|
|
26
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar :
|
|
27
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar :
|
|
28
|
Elisei R, Schlumberger MJ, Müller SP,
Schöffski P, Brose MS, Shah MH, Licitra L, Jarzab B, Medvedev V,
Kreissl MC, et al: Cabozantinib in progressive medullary thyroid
cancer. J Clin Oncol. 31:3639–3646. 2013. View Article : Google Scholar :
|
|
29
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar
|
|
30
|
Dhillon A, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar
|
|
31
|
Bradham C and McClay DR: p38 MAPK in
development and cancer. Cell Cycle. 5:824–828. 2006. View Article : Google Scholar
|
|
32
|
Zatelli MC, Piccin D, Tagliati F, Bottoni
A, Luchin A and Uberti EC degli: SRC homology-2-containing protein
tyrosine phosphatase-1 restrains cell proliferation in human
medullary thyroid carcinoma. Endocrinology. 146:2692–2698. 2005.
View Article : Google Scholar
|
|
33
|
Sumimoto H, Imabayashi F, Iwata T and
Kawakami Y: The BRAF-MAPK signaling pathway is essential for
cancer-immune evasion in human melanoma cells. J Exp Med.
203:1651–1656. 2006. View Article : Google Scholar :
|
|
34
|
Dranoff G: Cytokines in cancer
pathogenesis and cancer therapy. Nat Rev Cancer. 4:11–22. 2004.
View Article : Google Scholar
|
|
35
|
Fiore L, Pollina LE, Fontanini G, Casalone
R, Berlingieri MT, Giannini R, Pacini F, Miccoli P, Toniolo A,
Fusco A and Basolo F: Cytokine production by a new undifferentiated
human thyroid carcinoma cell line, FB-1. J Clin Endocrinol Metab.
82:4094–4100. 1997. View Article : Google Scholar
|
|
36
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-kB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar
|
|
37
|
Caamano J and Hunter CA: NF-kappaB family
of transcription factors: Central regulators of innate and adaptive
immune functions. Clin Microbiol Rev. 15:414–429. 2002. View Article : Google Scholar :
|
|
38
|
Lewander A, Butchi AK, Gao J, He LJ,
Lindblom A, Arbman G, Carstensen J, Zhang ZY and Sun XF; Swedish
Low-Risk Colorectal Cancer Study Group, : Polymorphism in the
promoter region of the NFKB1 gene increases the risk of sporadic
colorectal cancer in Swedish but not in Chinese populations. Scand
J Gastroenterol. 42:1332–1338. 2007. View Article : Google Scholar
|
|
39
|
Curran JE, Weinstein SR and Griffiths LR:
Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA and
their involvement in sporadic breast cancer. Cancer Lett.
188:103–107. 2002. View Article : Google Scholar
|
|
40
|
Riemann K, Becker L, Struwe H, Rübben H,
Eisenhardt A and Siffert W: Insertion/deletion polymorphism in the
promoter of NFKB1 as a potential molecular marker for the risk of
recurrence in superficial bladder cancer. Int J Clin Pharmacol
Ther. 45:423–430. 2007. View
Article : Google Scholar
|
|
41
|
Zhang P, Wei Q, Li X, Wang K, Zeng H, Bu H
and Li H: A functional insertion/deletion polymorphism in the
promoter region of the NFKB1 gene increases susceptibility for
prostate cancer. Cancer Genet Cytogenet. 191:73–77. 2009.
View Article : Google Scholar
|
|
42
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar :
|
|
43
|
Zeki K, Morimoto I, Arao T, Eto S and
Yamashita U: Interleukin-1alpha regulates G1 cell cycle progression
and arrest in thyroid carcinoma cell lines NIM1 and NPA. J
Endocrinol. 160:67–73. 1999. View Article : Google Scholar
|
|
44
|
Hoffman B and Liebermann D: Apoptotic
signaling by c-MYC. Oncogene. 27:6462–6472. 2008. View Article : Google Scholar
|
|
45
|
Ellwood-Yen K, Graeber TG, Wongvipat J,
Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV and Sawyers CL:
Myc-driven murine prostate cancer shares molecular features with
human prostate tumors. Cancer Cell. 4:223–238. 2003. View Article : Google Scholar
|
|
46
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.
|
|
47
|
Khosla S, Oursler M, Schroeder M and
Eberhardt N: Transforming growth factor-beta 1 induces growth
inhibition of a human medullary thyroid carcinoma cell line despite
an increase in steady state c-myc messenger ribonucleic acid
levels. Endocrinology. 135:1887–1893. 1994. View Article : Google Scholar
|
|
48
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally
invasive biomarkers for breast cancer. Ann Surg. 251:499–505. 2010.
View Article : Google Scholar
|
|
49
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar
|
|
50
|
Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP and
Zhuang SM: MicroRNA-195 suppresses tumorigenicity and regulates
G1/S transition of human hepatocellular carcinoma cells.
Hepatology. 50:113–121. 2009. View Article : Google Scholar
|
